Crossmark

Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s13195-019-0491-2

Published Online: 2019-05-01

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Metaxas, Athanasios http://orcid.org/0000-0002-8747-7068
Anzalone, Marco

Vaitheeswaran, Ramanan

Petersen, Sussanne

Landau, Anne M.

Finsen, Bente
Funding

Funding for this research was provided by:

Fonden til Lægevidenskabens Fremme (15-267)

Syddansk Universitet (SDU2020)
License Information

Text and Data Mining valid from 2019-05-01
More Information

Article History

Received: 25 February 2019

Accepted: 4 April 2019

First Online: 1 May 2019

Ethics approval

: All procedures were approved by the Danish Animal Ethics Inspectorate (nr 2011/561-1950) and complied with European Union directive 2010/63/EU, regulating animal research.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below